Charlotte Beau-Larvor

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 5 EPO patents. Top assignees: Pierre Fabre Medicament, Peirre Fabre Medicament. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charlotte Beau-Larvor. Retrieved from https://idiyas.com/inventor/charlotte-beau-larvor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 90.9

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 30(Granted Patents)

Company Filing History:

10 out of 269

Pierre Fabre Medicament

patents

1 out of 1

Peirre Fabre Medicament

patent

Years Active: 2015-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11661457 - IGF-1R antibody-drug-conjugate and its use for the treatment of cancer (2023-05-30),

2. 11365259 - IGF-1R antibody and its use as addressing vehicle for the treatment of cancer (2022-06-21),

3. 11219693 - Antibody-drug-conjugate and its use for the treatment of cancer (2022-01-11),

4. 10858423 - Composition for the treatment of IGF-1R expressing cancer (2020-12-08),

5. 10633448 - IGF-1R antibody-drug-conjugate and its use for the treatment of cancer (2020-04-28),

6. 10314921 - Antibody-drug-conjugate and its use for the treatment of cancer (2019-06-11),

7. 10202458 - IGF-1R antibody and its use as addressing vehicle for the treatment of cancer (2019-02-12),

8. 10161930 - Antigen binding protein and its use as addressing product for the treatment of cancer (2018-12-25),

9. 9689862 - Antigen binding protein and its use as addressing product for the treatment of cancer (2017-06-27),

10. 9624308 - Antigen binding proteins (2017-04-18),

11. 9173962 - Antigen binding protein and its use as addressing product for the treatment of cancer (2015-11-03),

Title: Charlotte Beau-Larvor: Pioneering Female Inventor from Jonzier Epagny, FR

Introduction: Charlotte Beau-Larvor is a trailblazing inventor hailing from the picturesque town of Jonzier Epagny in France. With a passion for innovation and a drive to make a difference, she has made significant contributions to the field of technology.

Latest Patents: Charlotte Beau-Larvor holds several patents in the areas of sustainable energy solutions and eco-friendly transportation. Her most recent patent involves a revolutionary design for a solar-powered vehicle that aims to reduce carbon emissions and promote environmental sustainability.

Career Highlights: Throughout her career, Charlotte Beau-Larvor has been recognized for her groundbreaking work in renewable energy and clean technology. Her innovative ideas have not only garnered attention within the industry but have also inspired a new generation of inventors to think outside the box.

Collaborations: Charlotte Beau-Larvor has collaborated with leading research institutions and universities to further her research and bring her inventions to life. By partnering with experts in the field, she has been able to push the boundaries of innovation and create solutions that have a lasting impact.

Conclusion: Charlotte Beau-Larvor's dedication to innovation and her commitment to creating a more sustainable future have solidified her reputation as a pioneering female inventor. Her work continues to inspire others to think creatively and strive for excellence in the world of technology.

Profile summary based on public USPTO records.